143 related articles for article (PubMed ID: 38288103)
1. Radiomics nomogram for preoperative differentiation of early-stage serous borderline ovarian tumors and serous malignant ovarian tumors.
Yu X; Zou Y; Wang L; Yang H; Jiao J; Yu H; Zhang S
Front Oncol; 2023; 13():1269589. PubMed ID: 38288103
[TBL] [Abstract][Full Text] [Related]
2. MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors.
Yu XP; Wang L; Yu HY; Zou YW; Wang C; Jiao JW; Hong H; Zhang S
Cancer Manag Res; 2021; 13():329-336. PubMed ID: 33488120
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Ovarian Tumors with Multidetector Computed Tomography and Tumor Markers: Differentiation of Stage I Serous Borderline Tumors and Stage I Serous Malignant Tumors Presenting as Solid-Cystic Mass.
Yu XP; Liu Y; Jiao JW; Yang HJ; Wang RJ; Zhang S
Med Sci Monit; 2020 Aug; 26():e924497. PubMed ID: 32801292
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of a CT-based radiomics nomogram for discrimination of benign and early stage malignant ovarian tumors.
Chen J; Yang F; Liu C; Pan X; He Z; Fu D; Jin G; Su D
Eur J Med Res; 2023 Dec; 28(1):609. PubMed ID: 38115095
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Ovarian Neoplasms Using Nomogram in Combination With Ultrasound Image-Based Radiomics Signature and Clinical Factors.
Qi L; Chen D; Li C; Li J; Wang J; Zhang C; Li X; Qiao G; Wu H; Zhang X; Ma W
Front Genet; 2021; 12():753948. PubMed ID: 34650603
[No Abstract] [Full Text] [Related]
6. Preoperative prediction of miliary changes in the small bowel mesentery in advanced high-grade serous ovarian cancer using MRI radiomics nomogram.
Guo Q; Lin Z; Lu J; Li R; Wu L; Deng L; Qiang J; Wu X; Gu Y; Li H
Abdom Radiol (NY); 2023 Mar; 48(3):1119-1130. PubMed ID: 36651979
[TBL] [Abstract][Full Text] [Related]
7. Radiomics nomogram for prediction of microvascular invasion in hepatocellular carcinoma based on MR imaging with Gd-EOB-DTPA.
Zhang S; Duan C; Zhou X; Liu F; Wang X; Shao Q; Gao Y; Duan F; Zhao R; Wang G
Front Oncol; 2022; 12():1034519. PubMed ID: 36387156
[TBL] [Abstract][Full Text] [Related]
8. A Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma.
Yang L; Gu D; Wei J; Yang C; Rao S; Wang W; Chen C; Ding Y; Tian J; Zeng M
Liver Cancer; 2019 Oct; 8(5):373-386. PubMed ID: 31768346
[TBL] [Abstract][Full Text] [Related]
9. Radiomics Nomogram for Identifying Sub-1 cm Benign and Malignant Thyroid Lesions.
Wu X; Li J; Mou Y; Yao Y; Cui J; Mao N; Song X
Front Oncol; 2021; 11():580886. PubMed ID: 34164333
[TBL] [Abstract][Full Text] [Related]
10. A Radiomics Nomogram Integrated With Clinic-Radiological Features for Preoperative Prediction of DNA Mismatch Repair Deficiency in Gastric Adenocarcinoma.
Tong Y; Li J; Chen J; Hu C; Xu Z; Duan S; Wang X; Yu R; Cheng X
Front Oncol; 2022; 12():865548. PubMed ID: 35912185
[TBL] [Abstract][Full Text] [Related]
11. A CT-Based Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Periampullary Carcinomas.
Bi L; Liu Y; Xu J; Wang X; Zhang T; Li K; Duan M; Huang C; Meng X; Huang Z
Front Oncol; 2021; 11():632176. PubMed ID: 34395237
[TBL] [Abstract][Full Text] [Related]
12. Application Values of 2D and 3D Radiomics Models Based on CT Plain Scan in Differentiating Benign from Malignant Ovarian Tumors.
Li S; Liu J; Xiong Y; Han Y; Pang P; Luo P; Fan B
Biomed Res Int; 2022; 2022():5952296. PubMed ID: 35224097
[TBL] [Abstract][Full Text] [Related]
13. Radiomics nomogram for differentiating between benign and malignant soft-tissue masses of the extremities.
Wang H; Nie P; Wang Y; Xu W; Duan S; Chen H; Hao D; Liu J
J Magn Reson Imaging; 2020 Jan; 51(1):155-163. PubMed ID: 31169956
[TBL] [Abstract][Full Text] [Related]
14. Development of a radiomic-clinical nomogram for prediction of survival in patients with serous ovarian cancer.
Hong Y; Liu Z; Lin D; Peng J; Yuan Q; Zeng Y; Wang X; Luo C
Clin Radiol; 2022 May; 77(5):352-359. PubMed ID: 35264303
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a CT-based nomogram for preoperative prediction of clear cell renal cell carcinoma grades.
Zheng Z; Chen Z; Xie Y; Zhong Q; Xie W
Eur Radiol; 2021 Aug; 31(8):6078-6086. PubMed ID: 33515086
[TBL] [Abstract][Full Text] [Related]
16. DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
Zhou Y; Zhou G; Zhang J; Xu C; Zhu F; Xu P
Eur Radiol; 2022 Jul; 32(7):5004-5015. PubMed ID: 35128572
[TBL] [Abstract][Full Text] [Related]
17. CT-based radiomics nomogram analysis for assessing BRCA mutation status in patients with high-grade serous ovarian cancer.
Cao Y; Jiang Y; Song J; Zhang A; Duan S; Chen T; Wu F; Cheng W
Acta Radiol; 2023 Oct; 64(10):2802-2811. PubMed ID: 37553913
[TBL] [Abstract][Full Text] [Related]
18. A radiomics nomogram based on multiparametric MRI might stratify glioblastoma patients according to survival.
Zhang X; Lu H; Tian Q; Feng N; Yin L; Xu X; Du P; Liu Y
Eur Radiol; 2019 Oct; 29(10):5528-5538. PubMed ID: 30847586
[TBL] [Abstract][Full Text] [Related]
19. A CT-based radiomics nomogram for differentiation of focal nodular hyperplasia from hepatocellular carcinoma in the non-cirrhotic liver.
Nie P; Yang G; Guo J; Chen J; Li X; Ji Q; Wu J; Cui J; Xu W
Cancer Imaging; 2020 Feb; 20(1):20. PubMed ID: 32093786
[TBL] [Abstract][Full Text] [Related]
20. Preoperative contrast-enhanced CT-based radiomics nomogram for differentiating benign and malignant primary retroperitoneal tumors.
Xu J; Guo J; Yang HQ; Ji QL; Song RJ; Hou F; Liang HY; Liu SL; Tian LT; Wang HX
Eur Radiol; 2023 Oct; 33(10):6781-6793. PubMed ID: 37148350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
